Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41586-021-03491-6

http://scihub22266oqcxt.onion/10.1038/s41586-021-03491-6
suck pdf from google scholar
33827113!7611055!33827113
unlimited free pdf from europmc33827113    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33827113      Nature 2021 ; 594 (7861): 88-93
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia #MMPMID33827113
  • Braga L; Ali H; Secco I; Chiavacci E; Neves G; Goldhill D; Penn R; Jimenez-Guardeno JM; Ortega-Prieto AM; Bussani R; Cannata A; Rizzari G; Collesi C; Schneider E; Arosio D; Shah AM; Barclay WS; Malim MH; Burrone J; Giacca M
  • Nature 2021[Jun]; 594 (7861): 88-93 PMID33827113show ga
  • COVID-19 is a disease with unique characteristics that include lung thrombosis(1), frequent diarrhoea(2), abnormal activation of the inflammatory response(3) and rapid deterioration of lung function consistent with alveolar oedema(4). The pathological substrate for these findings remains unknown. Here we show that the lungs of patients with COVID-19 contain infected pneumocytes with abnormal morphology and frequent multinucleation. The generation of these syncytia results from activation of the SARS-CoV-2 spike protein at the cell plasma membrane level. On the basis of these observations, we performed two high-content microscopy-based screenings with more than 3,000 approved drugs to search for inhibitors of spike-driven syncytia. We converged on the identification of 83 drugs that inhibited spike-mediated cell fusion, several of which belonged to defined pharmacological classes. We focused our attention on effective drugs that also protected against virus replication and associated cytopathicity. One of the most effective molecules was the antihelminthic drug niclosamide, which markedly blunted calcium oscillations and membrane conductance in spike-expressing cells by suppressing the activity of TMEM16F (also known as anoctamin 6), a calcium-activated ion channel and scramblase that is responsible for exposure of phosphatidylserine on the cell surface. These findings suggest a potential mechanism for COVID-19 disease pathogenesis and support the repurposing of niclosamide for therapy.
  • |*Cell Fusion[MESH]
  • |*Drug Evaluation, Preclinical[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |Alveolar Epithelial Cells/drug effects/pathology/virology[MESH]
  • |Animals[MESH]
  • |Anoctamins/*antagonists & inhibitors/metabolism[MESH]
  • |COVID-19/metabolism/*pathology/virology[MESH]
  • |Calcium Signaling/drug effects[MESH]
  • |Cell Line[MESH]
  • |Chloride Channels/metabolism[MESH]
  • |Chlorocebus aethiops[MESH]
  • |Female[MESH]
  • |Giant Cells/*drug effects/metabolism/virology[MESH]
  • |Humans[MESH]
  • |Lung/drug effects/pathology/virology[MESH]
  • |Male[MESH]
  • |SARS-CoV-2/*drug effects/metabolism/pathogenicity[MESH]
  • |Spike Glycoprotein, Coronavirus/*antagonists & inhibitors/metabolism[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box